the john dirks canada gairdner global health award recognizes the world’s leading researchers who have used rational, scientifically based research to improve the wellbeing of those facing health inequalities worldwide. while a single significant scientific discovery would continue to be sufficient evidence to select a nominee, the award will also recognize outstanding researchers who apply rational scientific approaches to successful implementation, evaluation and policy interventions.

gairdner invites nominations from any field of research impacting global health and health inequity. the award is intended for research-focused candidates, not those primarily involved in administrative or advocacy roles. this award can be shared by multiple recipients at the discretion of the foundation.

quality nominations are essential to the evaluation process for this award. packages should be accurate, current, and complete throughout the five year period of consideration. the nomination portal is open each year from mid-april- october 1 for edits, changes or additions by nominators.

the canada gairdner wightman award recognizes a canadian health researcher who has demonstrated extraordinary leadership paired with exceptional science. successful nominees will demonstrate research excellence in the health sciences at an international level as well as superior leadership among their peers, with local, national and international impact. outstanding candidates at varied levels of career development are eligible.

quality nominations are essential to the evaluation process for this award. packages should be accurate, current, and complete throughout the five year period of consideration. the nomination portal is open each year from mid-april- october 1 for edits, changes or additions by nominators.

the sickkids foundation-cihr-ihdcyh new investigator research grants in child and youth health program seeks to strengthen canada’s capacity and knowledge to respond to children’s health challenges and needs. the grants are jointly sponsored by sickkids foundation and the cihr institute of human development, child and youth health (ihdcyh). new investigators (also referred to by cihr as early career researchers) may obtain up to three years’ support for research in biomedical, clinical, health systems and services, population and public health sectors that has the potential for significant impact on children’s health outcomes.

the specific objectives of this funding opportunity are:

• to understand and address the acute mental health and/or substance use needs of individuals, communities and/or populations, and/or the effects on related care systems, due to the covid-19 pandemic; and
• to develop the evidence to better match access to mental health and/or substance use services with the people who need them the most, in the context of the covid-19 pandemic.

applications must be in alignment with both of the objectives to be deemed relevant to this funding opportunity.

the azrieli foundation is pleased to announce the “back on track from covid19” funding opportunity for clinical and fundamental researchers working in the area of neurodevelopmental disorders. 

this opportunity addresses the interruption to biomedical research laboratories and clinical research as a result of the covid19 emergency.

the funds are intended to cover costs to research incurred by facility shutdown or changes in work plans due to social distancing, assisting graduate student progress to complete research, and to mitigate the loss of promising discoveries and ideas.

the award (up to $cdn 10,000) will be used to supplement an already awarded peer-reviewed grant/project, and selection will prioritize early career researchers.

to access the application form, instructions and timelines, please visit our website.

please send inquiries to: science.grants@azrielifoundation.org

connection grants are expected to respond to the objectives of the connection program.

these grants support events and outreach activities geared toward short-term, targeted knowledge mobilization initiatives. these events and activities represent opportunities to exchange knowledge and to engage on research issues of value to those participating. events and outreach activities funded by a connection grant may often serve as a first step toward more comprehensive and longer-term projects.

connection grants support workshops, colloquiums, conferences, forums, summer institutes, or other events or outreach activities that facilitate:

• disciplinary and/or interdisciplinary exchanges in the social sciences and humanities;
• scholarly exchanges between those working in the social sciences and humanities and those working in other research fields;
• intersectoral exchanges between academic researchers in the social sciences and humanities and researchers and practitioners from the public, private and/or not-for-profit sectors; and/or
• international research collaboration and scholarly exchanges with researchers, 世界杯2022赛程表淘汰赛 and non-academic partners from other countries.

nserc is pleased to announce a jointly funded initiative with environment and climate change canada to support research that will increase scientific knowledge to achieve canada’s zero plastic waste targets and to inform the advancement of policy and regulatory measures.

this call focuses on research to detect and characterize plastics in the environment, and exposure and effects of plastics on wildlife and human health. the funding will support a series of multidisciplinary, collaborative projects in an effort to increase research capacity, as well as collaboration, to help close the gaps in our understanding of plastic pollution and its impacts. the aim is to generate new knowledge to support policy and decision-making related to plastic pollution, as well as to the objectives of the canada-wide strategy on zero plastic waste.

for more information about this funding opportunity, please refer to the call for proposals. for all questions, please contact rp-initiatives-pr@nserc-crsng.gc.ca.

the fy20 defense appropriations act provides funding to the department of defense duchenne muscular dystrophy research program (dmdrp) to support research addressing discovery and development of therapeutics, devices, and other interventions.  as directed by the office of the assistant secretary of defense for health affairs, the defense health agency j9, research and development directorate manages the defense health program (dhp) research, development, test, and evaluation (rdt&e) appropriation.  the managing agent for the anticipated program announcements/funding opportunities is the congressionally directed medical research programs (cdmrp) at the u.s. army medical research and development command (usamrdc).

the fy20 dmdrp program announcements and general application instructions for the following award mechanisms are posted on the grants.gov website.    

https://cdmrp.army.mil/funding/dmdrp

idea development award – pre-application due august 12, 2020

independent investigators at all academic levels (or equivalent).

• supports the development of innovative, high-impact ideas that advance the understanding of duchenne muscular dystrophy (dmd) and ultimately lead to improved outcomes.
• must address opportunities and challenges in the development of safe and effective macromolecular and cellular therapies that address primary pathology of dmd.  eligible therapeutic strategies include: gene therapy, genome editing, oligonucleotide therapies, exon skipping, protein therapeutics, and cell therapies. therapies that will be efficacious across the life-span, particularly in adolescents and adults are encouraged.
• preliminary data are required.
• clinical trials are not allowed.
• maximum funding of $350,000 for direct costs (plus indirect costs).
• maximum period of performance is 2 years

translational research partnership award – pre-application due august 12, 2020

investigators at or above the level of assistant professor (or equivalent)

• supports the development of translational research collaborations between two independent investigators to address a critical problem or question in dmd and to accelerate the movement of promising ideas into clinical application.
• partnerships where one partner in the collaboration is a research scientist and the other is a clinician are strongly encouraged.
• must address one of the fy20 translational research partnership award focus areas
• preliminary data are required.
• clinical trials are allowed.
• maximum combined funding of $1,200,000 for direct costs (plus indirect costs)
• maximum period of performance is 3 years

a pre-application is required and must be submitted through the electronic biomedical research application portal (ebrap) at https://ebrap.org prior to the pre-application deadline.  all applications must conform to the final program announcements and general application instructions available for electronic downloading from the grants.gov website.  the application package containing the required forms for each award mechanism will also be found on grants.gov.  a listing of all cdmrp and other usamrdc extramural funding opportunities can be obtained on the grants.gov website by performing a basic search using cfda number 12.420. 

for email notification when program announcements are released, subscribe to program-specific news and updates under “email subscriptions” on the ebrap homepage at https://ebrap.org.  for more information about the dmdrp or other cdmrp-administered programs, please visit the cdmrp website (https://cdmrp.army.mil).

point of contact:

cdmrp help desk
301-682-5507
help@ebrap.org